Tragara Pharmaceuticals will participate at the 2008 BIO-Europe Spring Conference, April 7-9, 2008, at the Palacio Municipal de Congresos in Madrid, Spain, where president and CEO Thomas M. Estok will participate in the panel "Beyond Targeted Therapeutics – How will Pharma Value the Next Generation of Oncology Companies". Also participating on the panel will be Dr. Martin Buckland, Chief Business Officer, Astex Therapeutics; Dr. Mohamed Ragab, Pharma Partnering Oncology Leader, Hoffmann-La Roche; and Dr. George S. Golumbeski, Vice President, Business Development, Licensing and Strategy Oncology, Novartis Pharmaceuticals

The panel discussion will occur on April 7 at 2:45 pm and will be moderated Tim Haines, Partner with Abingworth Management Ltd.